Dishman Carbogen Amcis Limited
HSBC Mutual Fund increased its stake in Dishman Carbogen Amcis from 1.06% to 1.41%, raising its holding by 558,579 shares.
A contract research and manufacturing services provider specializing in pharmaceuticals and specialty chemicals. Dishman Carbogen delivers comprehensive CRAMS solutions alongside manufacturing marketable molecules including vitamins, specialty chemicals, and disinfectants. With operations spanning Switzerland, the UK, Europe, China, and other countries, the company serves global pharmaceutical and chemical clients. Its integrated approach combines research capabilities with large-scale manufacturing infrastructure to support drug development and production across multiple international markets.
Indian arm of HSBC Asset Management, the investment arm of HSBC Group with over USD 600 billion in global AUM. Manages over Rs 1 lakh crore in India across equity, debt and hybrid schemes. Previously known for integration of L&T Mutual Fund schemes after acquiring it from L&T Finance in 2022, which significantly expanded the franchise.